Taj Pharma Russia Ltd. is a wholly owned subsidiary of Taj Pharma Group, which is a pharmaceutical company based in Russia and listed on the MOEX Moscow Stock Exchange exchange. The Taj Pharma RUSSIA offices were opened in Saint Petersburg in 1996. Our principal role is to represent Taj’s pharmaceutical products in the RUSSIA. Our focus is on Prescription Only Medicine (POM) including a broad selection of human preparations as well as active pharmaceutical ingredients. Our key franchises are Cardiology, Respiratory, Critical Care, CNS and Oncology products.

In the spirit of the values which are common to all units and employees of the Group, we endeavour to provide innovative medicinal treatments and best quality service to patients, healthcare professionals and the community in the RUSSIA, the region we operationally cover.

Our website

This local website of Taj Pharma concentrates on providing the regulatory information required to be accessible and available on the internet for RUSSIA patients and healthcare providers. For understanding more about the Taj Group, its businesses, products and operations, you are advised to visit www.tajpharma.ru , the corporate website providing a plentiful package of up-to-date information about Taj. Our website is integrally linked to the corporate website, in parallel with numerous other sub-sites under the Taj brand.

Taj Pharma Russia Support Story

On occasions we support charities/Patient organisations that are part of the therapeutic areas Taj Support Programme & Taj Donations & Grants by year.

Products & Services

For Patients:

We would like to remind you that if you get any side effects, talk to your doctor, pharmacist or nurse. Medicines includes any possible side effects not listed in the package leaflet. You can also report side effects directly to our pharmacovigilance team. By reporting side effects you can help provide more information on the safety of this medicine.

For Healthcare Professionals:

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions to our pharmacovigilance, via the adverse events should also be reported to Taj Pharma. If you have any further questions, please contact Taj Pharma on 07635 520300 or at our office address.

Prescription drugs and self-care products

Taj has a wide range of primary healthcare prescription drugs and other products for treatment and prevention of the commonest illnesses. Our Russia and CIS portfolio consists of a range of almost 400 products.

Our product portfolio includes:

    • Proprietary drugs developed by Taj itself
  • Self-care products such as non-prescription medicines, basic ointments and vitamins

Welcome to Taj Pharma UK Limited!

Taj Pharma UK Limited is a small but fast growing pharmaceutical company based in Watford United Kingdom engaged in the acquisition, development, marketing and distribution of a wide range of generic medicines, as well as OTC brands. Growth at Taj is driven by a focus on quality excellence in every aspect of product development, manufacture and distribution.

This quality emphasis has laid a foundation for Taj to grow, from modest beginnings in 1995, to be amongst one of the most reliable suppliers of pharmaceutical products in the UK today, with several NHS contracts and ongoing OLS agreements in place.

Our heritage OTC brands have become the standard for treatment/ usage within their therapeutic segments and also demonstrate continued growth in the retail sector.

Manufacturing of most of our generics is now carried out by our parent company Taj Pharma at their world class manufacturing plants, based in Maharashtra, India.

Taj Pharma India

Generic Products

Taj products add value to healthcare systems by providing high quality medicines that are affordable. With a diverse and rapidly growing product range, we cover a number of therapeutic segments.

Over The Counter medicines/ formulations

The Quality Driven Values at Taj has fuelled our growth in recent years, in the challenging environment of generic markets in the UK we continue to grow our OTC brands to supplement this generic activity..


Our diverse range of products manufactured by our parent company Taj Pharma Limited is a testimony to our commitment to make a positive contribution to the healthcare system. We are constantly evaluating the feasibility of products designed to reduce the cost of manufacturing, while retaining the safety and efficacy of the product molecule. There is a constant endeavour to formulate newer generics and make them available to the health care providers.

Our finished dosage form products, due to our quality driven value system ensures that the product made available to the consumer is of the highest standard of quality and efficacy.

Taj Pharma UK Limited play a small but important role in the UK generic market. It has a diverse product portfolio of 64 molecules, 84 licenses offering over 400 presentations, with more in the pipeline. We are focused on developing/acquiring more generics across the range.

Taj’s wide range of products covers the following therapeutic classes:

    • Analgesics
    • Anti-Infectives
    • Anti hypertensives
    • Anti depressants
  • Anti spasmodics

Chemotherapy-Induced Nausea and Vomiting

Nausea and vomiting continues to affect patients undergoing cancer therapy.

Chemotherapy-Induced Nausea and Vomiting are a common side-effects of cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments.

Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Management of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.

Many valuable development opportunities get lost in translation from academia to industry. Taj Pharma is dedicated to identifying these opportunities and ensuring that the value in the underlying pharmaceutical assets is preserved. We achieve this through alignment of IP and licencing strategies with the drug development process.

Taj Pharma team are highly qualified and experienced, and supported by a large network of skilled independent industry experts.

With agility that is unparalleled in the industry, we are ready to help guide viable projects into market-ready products and ensure that the true value of innovation is retained.

Approximately 1 in 6 people will suffer major depression at one point in their lives, and while there are various antidepressants on the market, many patients remain severely undertreated.

Current first-line therapies take between 3 and 12 weeks to work, and it is often during this long lag-time that the most debilitating symptoms of depression occur. In addition, around 40% of patients remain clinically ill after a year of treatment, highlighting the urgent need for alternative therapies.

We have identified an innovative solution to bridge this gap by developing a rapid-acting antidepressant.

Taj Pharma Services has manufactured a wide range of solid dose, powders and hard gel capsules since 1995. Our facilities can manufacture existing and new formulations, providing innovative solutions for your hard-to-manufacture products. We have licences for the manufacture of hormones, controlled drugs, specials and investigational medicinal products (IMPs). Our facilities and services are certified by the Food and Drug Regulatory Agency (FDA).

Taj Pharma Services project managers form a critical part of each project, ensuring that every programme is delivered on time and in full. Your project manager will coordinate every process in each phase of your programme to meet your timelines and budget. As a key member of your product and process development team, your project manager will ensure all your technical requirements are met and will work with you to resolve any regulatory challenge you encounter.

All of our project managers have more than a decade of experience within the pharmaceutical industry, having managed programmes from both clinical and commercial sectors. Custom requires that our project managers be certified to apply these principles across all our client programmes. Taj also ensures that the team is highly knowledgeable in the principles of Good Manufacturing Practices, Good Distribution Practices and clinical trial supply management.

Taj consider our work to help bring lifesaving and life-enhancing products to the market to be an honour. That’s why our project managers treat every programme as if it is their own. Taj will communicate with you at every stage, updating you on the progress of your project at every stage throughout the development life cycle and responding quickly and appropriately to your specific needs.

Labels: taj pharmaceuticals limited, taj pharmaceuticals limited Bombay, taj pharmaceuticals limited mumbai, taj pharmaceuticals limited promoters, taj pharmaceuticals promoters, taj pharma promoters, taj pharma Bombay, Taj Pharmaceuticals mumbai, Taj Pharmaceuticals Bombay


| | | | | | | |